North America Catheters Market Outlook, 2030

The North American catheter market has become a vital segment of the medical device industry, driven by technological advancements, an aging population, and a rising prevalence of chronic diseases. The demand for catheters in the region is largely fueled by the increasing incidence of cardiovascular diseases, diabetes, and renal disorders, as well as conditions like peripheral artery disease that require frequent catheterization procedures. The aging population further amplifies this demand, as older adults are more prone to conditions that necessitate catheter-based interventions.

Technological innovations have significantly contributed to market expansion, with developments such as antimicrobial coatings, sensor-integrated catheters, and steerable tips enhancing the safety, precision, and efficacy of procedures. These innovations have helped reduce catheter-associated infections and improved patient outcomes, reinforcing the adoption of advanced catheter solutions. The regulatory framework in North America, particularly the United States, provides clear guidelines for the approval and monitoring of catheter devices, ensuring their safety and effectiveness, while reimbursement policies under public health programs have increased access to catheter-based treatments.

The market is segmented into various types, with cardiovascular catheters leading due to the high prevalence of heart-related conditions, followed by urological and neurovascular catheters driven by urinary and neurosurgical demands. In terms of product design, single-use or disposable catheters dominate the market due to their convenience and lower risk of infection. In January 2025, Dr. Bruce Gardner, a radiologist at Sanford Health, received U.S. FDA approval for his innovative catheter design to prevent accidental dislodgement injuries. The new catheter features a mechanism that allows the retention balloon to deflate rapidly when excessive tension is applied, thereby minimizing potential patient harm.

According to the research report "North America Catheters Market Outlook, 2030,", the North America Catheters market is anticipated to grow at more than 6.70% CAGR from 2025 to 2030. The increasing prevalence of chronic diseases such as cardiovascular conditions, diabetes, and renal disorders has led to a higher demand for catheter-based interventions. For instance, over 12 million individuals in the U.S. are affected by peripheral artery disease, necessitating catheterization procedures. The aging population further exacerbates this demand, as older adults are more susceptible to conditions requiring catheterization.

In December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, announced the U.S. launch of its R2P NaviCross Peripheral Support Catheter, further expanding its radial-to-peripheral (R2P) portfolio. Available in a 200-cm length, the catheter features a double-braided, stainless-steel construction designed to provide superior trackability and torque control, facilitating lesion crossing in complex procedures. Technological advancements have also played a crucial role in market expansion. Innovations such as antimicrobial coatings, steerable tips, and sensor-integrated catheters have enhanced the safety and efficacy of catheter-based procedures.

These innovations have not only improved patient outcomes but also reduced the incidence of catheter-associated infections, a significant concern in healthcare settings. The regulatory environment in North America, particularly in the United States, has been conducive to the growth of the catheter market. The U.S. Food and Drug Administration (FDA) has established clear guidelines for the approval and monitoring of catheter devices, ensuring their safety and effectiveness. Additionally, reimbursement policies under programs like Medicare and Medicaid have facilitated broader access to catheter-based treatments, further driving market growth.

The catheter market in North America is diverse, encompassing various types tailored to specific medical needs. Cardiovascular catheters have been the leading segment, attributed to the high incidence of heart-related conditions. In December 2024, the company's radial-to-peripheral (R2P) portfolio was further expanded when Terumo Interventional Systems (TIS), a part of Terumo Corporation, announced the introduction and commercial availability of its R2P™ NaviCross® peripheral support catheter in the United States.

Market Drivers

• Aging Population and Chronic Diseases: North America has a rapidly aging population, which increases the prevalence of chronic conditions such as cardiovascular diseases, diabetes, and kidney disorders. These conditions require frequent monitoring and interventions, which drives the demand for various catheter types including cardiovascular, urinary, and neurovascular catheters. Hospitals and clinics rely heavily on these devices to improve patient outcomes and manage long-term care efficiently.
• Technological Advancements in Catheters: Innovations such as antimicrobial coatings, drug-eluting catheters, and hydrophilic surfaces have improved the safety, effectiveness, and patient comfort of catheters. Additionally, developments in MRI-compatible and sensor-integrated catheters allow for more precise diagnostics and minimally invasive procedures, further boosting their adoption in hospitals and outpatient centers.

Market Challenges

• High Cost of Advanced Catheters: Specialized catheters with advanced features often come at a premium price, making them less accessible for smaller clinics or cost-conscious healthcare providers. This price sensitivity can limit market growth despite the clinical advantages these devices offer.
• Risk of Infections and Complications: Catheter-related infections and complications remain a significant concern for healthcare providers. Even with improved designs, improper usage or prolonged catheterization can lead to urinary tract infections or bloodstream infections, which may restrict their use or increase regulatory scrutiny.

Market Trends

• Growth of Minimally Invasive Procedures: There is a strong shift toward minimally invasive surgeries and interventions. Catheters are central to these procedures, reducing recovery times, lowering infection risks, and improving patient comfort. Hospitals are increasingly adopting these techniques, driving consistent demand for specialized catheters.
• Rising Adoption of Home Healthcare: Home healthcare services are expanding in North America, supported by telemedicine and remote monitoring. Catheters suitable for home use, such as intermittent urinary catheters, are seeing higher demand, allowing patients to manage chronic conditions safely outside hospital settings.Cardiovascular catheters dominate the North America catheters industry due to the region’s high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong adoption of minimally invasive procedures.

In North America, cardiovascular catheters hold the largest market share within the catheter industry, primarily because of the alarming prevalence of cardiovascular diseases (CVDs) such as coronary artery disease, heart failure, and arrhythmias, which remain the leading causes of mortality in the United States and Canada. The aging population, sedentary lifestyle patterns, obesity, and increasing incidence of hypertension and diabetes have significantly contributed to the rising burden of heart-related conditions, thereby creating sustained demand for cardiovascular catheters used in diagnostic, therapeutic, and interventional procedures.

North America’s highly advanced healthcare infrastructure further supports this trend, as hospitals and specialized cardiac centers are well equipped with modern catheterization labs and advanced interventional cardiology technologies that rely heavily on catheter-based solutions. Moreover, the region has witnessed a strong shift toward minimally invasive surgeries, with both patients and healthcare providers preferring catheter-based procedures such as angioplasty, stent placement, electrophysiology studies, and ablation therapies because they offer reduced recovery time, shorter hospital stays, and lower procedural risks compared to open-heart surgeries. This preference has accelerated the adoption of cardiovascular catheters across the healthcare ecosystem. Additionally, favorable reimbursement policies and wide insurance coverage for cardiovascular interventions in the U.S. and Canada make such procedures more accessible to patients, which further strengthens demand.

Single-lumen catheters are the largest segment in the North America catheters industry because of their widespread use in routine medical procedures, cost-effectiveness, and broad applications across hospitals and homecare settings.

Unlike specialized or multi-lumen catheters, single-lumen designs are simple, cost-effective, and versatile, making them a first-line choice in most clinical settings. Their affordability plays a critical role in their dominance, as healthcare providers and hospitals often prefer devices that balance efficiency with cost containment, particularly in the U.S., where healthcare expenditure is high and hospitals must manage costs while meeting patient demand.

Another major factor behind their dominance is their suitability for both short-term and long-term applications, which makes them widely adopted not only in hospitals and ambulatory surgical centers but also in homecare settings where patients require catheter-based support for chronic conditions such as urinary incontinence, long-term IV therapy, or parenteral nutrition.

North America’s growing elderly population and the increasing burden of chronic diseases such as cancer, kidney disorders, and diabetes have led to a surge in the need for long-term patient management, thereby driving greater reliance on single-lumen catheters due to their simplicity and ease of use. Additionally, infection prevention is a key concern in U.S.

and Canadian healthcare systems, and single-lumen catheters are often considered safer for reducing the risk of catheter-associated infections compared to multi-lumen types, which can be more complex to maintain. Their straightforward design also allows healthcare workers to easily insert, monitor, and remove them, supporting high turnover in busy hospital environments. Favorable reimbursement policies for routine catheterization procedures and the widespread availability of single-lumen devices from leading manufacturers such as Becton Dickinson, Teleflex, and Medtronic further reinforce their high utilization rates.

Hospital stores dominate the North America catheters industry as the largest distribution channel because hospitals are the primary centers for high-volume catheter usage in surgeries, diagnostics, and chronic disease management, ensuring bulk procurement and consistent demand.

In North America, hospital stores stand as the largest distribution channel in the catheters industry due to the central role hospitals play in delivering comprehensive medical care and their high-volume consumption of catheters across multiple departments. Catheters are integral in various hospital-based procedures such as cardiovascular interventions, urological treatments, neurological procedures, critical care, and post-surgical management, making hospitals the single largest consumer group. Given the complexity and frequency of such procedures, hospitals maintain direct procurement through in-house stores, ensuring uninterrupted supply of different catheter types to meet urgent clinical needs.

This bulk purchasing not only guarantees better cost efficiency but also ensures hospitals have immediate access to a wide inventory, which is crucial in emergencies and high patient turnover environments. The dominance of hospital stores is further strengthened by the high prevalence of chronic and acute conditions in North America such as cardiovascular diseases, renal disorders, urinary incontinence, and cancer that require routine catheterization, with hospitals being the primary facilities handling advanced treatments for these conditions.

Moreover, the rise of minimally invasive procedures and advanced surgeries has further increased the reliance on specialized catheters, and hospital stores are best positioned to stock a wide range of products from multiple manufacturers. Another contributing factor is the favorable reimbursement structure in the U.S. and Canada, where most catheter-based procedures performed in hospitals are covered by insurance, thereby boosting patient admissions and catheter usage within hospital environments.

Hospitals and Ambulatory Surgical Centers (ASCs) are the largest end-user segment in the North America catheters industry because they handle the highest volume of complex and routine medical procedures requiring catheters, supported by advanced infrastructure, skilled professionals, and insurance coverage.

Catheters are indispensable tools in cardiovascular procedures, urology, neurology, oncology, critical care, and post-surgical management, all of which are predominantly carried out in hospitals and ASCs where advanced facilities and specialized care are available. The high prevalence of chronic diseases such as cardiovascular disorders, kidney failure, diabetes, and cancer across the U.S. and Canada has created sustained demand for catheter-based interventions, which are most often performed in these institutions.

Hospitals, being the first point of care for critical and emergency cases, consume the largest share of catheters, while ASCs have gained importance by offering minimally invasive, outpatient catheter-based procedures with shorter recovery times and lower costs. This dual role has significantly expanded the overall utilization of catheters in the region. Another major factor driving their dominance is the well-established healthcare infrastructure in North America, which includes modern catheterization laboratories, state-of-the-art surgical units, and highly trained interventional specialists, ensuring that catheter-based treatments are performed at the highest standards.

Favorable reimbursement policies and broad insurance coverage in the U.S. and Canada also encourage patients to seek hospital and ASC-based care, further boosting procedure volumes and catheter usage. Additionally, hospitals and ASCs maintain strong procurement channels, often purchasing catheters in bulk from leading manufacturers such as Medtronic, Boston Scientific, Abbott, and Becton Dickinson, ensuring consistent availability and adoption of the latest innovations, including drug-eluting, antimicrobial-coated, and imaging-enabled catheters.

The aging population in North America adds another layer of demand, as elderly patients frequently require catheterization for conditions such as urinary incontinence, vascular access, and long-term disease management, making hospitals and ASCs the primary sites for care delivery.The USA leads the North American catheter market due to advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong regulatory support for medical devices.

The United States dominates the North American catheter market because of its highly advanced healthcare infrastructure, widespread access to modern hospitals and specialty clinics, and a large base of skilled healthcare professionals. The country has one of the most technologically sophisticated medical ecosystems globally, with continuous investments in research and development that drive innovation in catheter design and functionality. Innovations such as drug-eluting catheters, biodegradable catheters, and minimally invasive interventional devices are rapidly adopted in the US, reflecting the high demand for advanced solutions that improve patient outcomes and reduce hospital stays.

Moreover, the prevalence of chronic diseases such as cardiovascular disorders, diabetes, and renal complications significantly increases the demand for catheters in both acute and long-term treatments. The US healthcare system, supported by comprehensive insurance coverage and reimbursement policies, facilitates patient access to high-quality catheter-based therapies, ensuring sustained market growth.

Regulatory support from bodies such as the FDA plays a crucial role, enabling the approval and safe introduction of innovative catheter technologies while maintaining strict quality and safety standards, which boosts both physician and patient confidence in these devices. Another factor contributing to the USA’s leadership is the presence of major global and regional catheter manufacturers headquartered in the country, fostering a competitive environment that encourages continuous product development and strategic partnerships.

***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.